Vickerman Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$440K Sell
478
-39
-8% -$39.5K 0.09% 72
2025
Q4
$556K Buy
517
+141
+38% +$135K 0.11% 70
2025
Q3
$287K Sell
376
-114
-23% -$84.8K 0.06% 73
2025
Q2
$382K Sell
490
-89
-15% -$69.2K 0.08% 67
2025
Q1
$478K Sell
579
-149
-20% -$124K 0.11% 66
2024
Q4
$562K Buy
728
+277
+61% +$229K 0.15% 55
2024
Q3
$400K Buy
+451
New +$405K 0.12% 57

Other funds holding LLY

Vickerman Investment Advisors's LLY Position: Q1 2026 in Review

Vickerman Investment Advisors reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $39.5K and leaving 478 shares worth $440K. The position accounts for 0.09% of the portfolio, ranked #72.

Vickerman Investment Advisors first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $562K in Q4 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vickerman Investment Advisors held 478 shares of Eli Lilly worth $440K as of Q1 2026.
  • Vickerman Investment Advisors sold 39 Eli Lilly shares in Q1 2026, an estimated $39.5K.
  • Eli Lilly made up 0.09% of Vickerman Investment Advisors's portfolio in Q1 2026, its #72 holding.
  • Vickerman Investment Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Vickerman Investment Advisors's Eli Lilly position peaked at $562K in Q4 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vickerman Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.